Capital Research Global Investors discloses 4.2% stake in BWIN (BWIN) via Schedule 13G/A
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Capital Research Global Investors filed an amended Schedule 13G reporting its beneficial ownership of The Baldwin Insurance Group, Inc. common stock. It reports beneficial ownership of 3,017,071 shares, representing 4.2% of the 71,589,503 shares believed to be outstanding as of the event date.
Capital Research Global Investors has sole voting and sole dispositive power over these 3,017,071 shares, with no shared voting or dispositive power. The filer certifies the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the company.
Positive
- None.
Negative
- None.
FAQ
What stake does Capital Research Global Investors report in BWIN's common stock?
Capital Research Global Investors reports beneficial ownership of 3,017,071 shares of The Baldwin Insurance Group, Inc. common stock, representing 4.2% of 71,589,503 shares believed outstanding. This ownership is reported as of the event date specified in the Schedule 13G/A filing.
Is Capital Research Global Investors part of a group in this BWIN Schedule 13G/A?
No group relationship is reported. The Schedule 13G/A identifies Capital Research Global Investors as the sole reporting person, with “Not Applicable” indicated for group identification and dissolution items, suggesting the position is not being reported as part of a coordinated group.
Is Capital Research Global Investors seeking to influence control of BWIN with this holding?
The filer certifies the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of The Baldwin Insurance Group, Inc., consistent with the passive investment intent typical of a Schedule 13G filing.
Who signed the Schedule 13G/A for Capital Research Global Investors regarding BWIN?
The Schedule 13G/A is signed by Jae Won Chung, identified as Vice President and Senior Counsel II of Capital Research and Management Company. The signature section also includes a certification that the information in the statement is true, complete and correct.